Rationel anvendelse af systemisk kortikosteroid i behandling af KOL, astma og allergisk rinitis
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 575 KB, PDF-dokument
The anti-inflammatory effect of systemic corticosteroid (CS) on obstructive lung diseases and seasonal allergic rhinitis is well known. So are the physiological side-effects of CS. A major development in inhalation and biologic treatment as well as hyposensibilisation has taken place in recent years and evidence of personalized use of CS in acute exacerbations increases. We review the side effects of CS and the rationale for use of systemic CS in treatment of obstructive lung diseases as asthma and COPD, as well as seasonal allergic rhinitis.
Bidragets oversatte titel | Rational use of systemic corticosteroid in the treatment of obstructive lung disease, asthma, and allergic rhinitis |
---|---|
Originalsprog | Dansk |
Artikelnummer | V09210680 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 184 |
Udgave nummer | 2 |
Antal sider | 9 |
ISSN | 0041-5782 |
Status | Udgivet - 10 jan. 2022 |
- Administration, Inhalation, Adrenal Cortex Hormones/adverse effects, Asthma/drug therapy, Humans, Rhinitis, Allergic/drug therapy, Rhinitis, Allergic, Seasonal/drug therapy
Forskningsområder
Links
- https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2022-01/v09210680_web.pdf
Forlagets udgivne version
ID: 325840165